| Literature DB >> 34040119 |
Chiyoe Shirota1, Hiroki Kawashima2, Takahisa Tainaka1, Wataru Sumida1, Kazuki Yokota1, Satoshi Makita1, Hizuru Amano1, Aitaro Takimoto1, Akinari Hinoki1, Hiroo Uchida3.
Abstract
Bile duct and anastomotic strictures and intrahepatic stones are common postoperative complications of congenital biliary dilatation (CBD). We performed double-balloon endoscopic retrograde cholangiography (DBERC) for diagnostic and therapeutic purposes after radical surgery. We focused on the effectiveness of DBERC for the treatment of postoperative complications of CBD patients. Bile duct and anastomotic strictures and intrahepatic stones are common postoperative complications of congenital biliary dilatation (CBD). We performed double-balloon endoscopic retrograde cholangiography (DBERC) for diagnostic and therapeutic purposes after radical surgery. We focused on the effectiveness of DBERC for the treatment of postoperative complications of CBD patients. This retrospective study included 28 patients who underwent DBERC (44 procedures) after radical surgery for CBD between January 2011 and December 2019. Strictures were diagnosed as "bile duct strictures" if endoscopy confirmed the presence of bile duct mucosa between the stenotic and anastomotic regions, and as "anastomotic strictures" if the mucosa was absent. The median patient age was 4 (range 0-67) years at the time of primary surgery for CBD and 27.5 (range 8-76) years at the time of DBERC. All anastomotic strictures could be treated with only by 1-2 courses of balloon dilatation of DBERC, while many bile duct strictures (41.2%) needed ≥ 3 treatments, especially those who underwent operative bile duct plasty as the first treatment (83.3%). Although the study was limited by the short follow-up period after DBERC treatment, DBERC is recommended as the first-line treatment for hepatolithiasis associated with biliary and anastomotic strictures in CBD patients, and it can be safely performed multiple times.Entities:
Year: 2021 PMID: 34040119 DOI: 10.1038/s41598-021-90550-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379